Paclitaxel-releasing balloon - MINVASYS

Drug Profile

Paclitaxel-releasing balloon - MINVASYS

Alternative Names: Danubio® Paclitaxel Eluting Balloon; Drug eluting balloon - MINVASYS; Paclitaxel Drug Eluting Balloon - MINVASYS

Latest Information Update: 14 Apr 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator MINVASYS
  • Class Antineoplastics; Diterpenes; Paclitaxels; Small molecules; Taxanes
  • Mechanism of Action Immunosuppressants; Mitosis inhibitors; Proto-oncogene protein c-bcl-2 inhibitors; Tubulin inhibitors; Tubulin polymerisation promoters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Coronary artery restenosis

Most Recent Events

  • 30 May 2013 Biomarkers information updated
  • 01 Mar 2012 Phase-II clinical trials in Coronary artery restenosis in France (Intracoronary) (NCT01485068)
  • 18 Jan 2012 Preclinical trials in Coronary artery restenosis in France (Intracoronary)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top